DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, ...

Caution is urged with early albumin use in septic shock and kidney impairment, especially with hyperoncotic vs isooncotic ...

A nephrologist (MT) confirmed the renal replacement therapy and its start date by reviewing the text of patients' medical records. We frequency matched controls (10 per case) on year of RRT as ...

In older ESRD patients on renal replacement therapy (RRT) with frailty phenotype, the risk of mortality at 1 year is three-times higher compared with ESRD patients without frailty phenotype.

Diality, a medical device company developing a smart, flexible hemodialysis platform, today announced successful completion ...

Regular follow-up of BMI can be a guiding tool for mortality estimation among geriatric peritoneal dialysis patients suggests ...

the treatment of kidney problems and renal replacement therapy. Systemic conditions that affect the kidneys (e.g. diabetes and autoimmune disease) and systemic problems that occur as a result of ...

The following is a summary of “Impact on fluid balance of an optimized restrictive strategy targeting non-resuscitative ...

A groundbreaking study published in BMC Nephrology found that metabolic dysfunction associated fatty liver disease (MAFLD) ...

New York, New York-- (Newsfile Corp. - December 31, 2024) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Outset Medical, Inc. (NASDAQ: ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...